Related Experiment Video
Updated: Jun 28, 2026
05:20
Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
TTF-1 expression in nephroblastoma.
Michele Bisceglia1, Moira Ragazzi, Carlos A Galliani
1Department of Pathology, IRCCS-Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo (FG), Italy. bismi@libero.it
The American Journal of Surgical Pathology
|November 18, 2008
Summary
Thyroid transcription factor-1 (TTF-1) was unexpectedly found in 16.6% of nephroblastomas, potentially leading to misdiagnosis. Further research is needed to understand the biological significance of this finding in kidney tumors.
Area of Science:
- Oncology
- Molecular Pathology
- Pediatric Pathology
Background:
- Nephroblastoma (Wilms tumor) is a common pediatric kidney cancer.
- Accurate diagnosis relies on characteristic histological features and protein expression.
- Thyroid transcription factor-1 (TTF-1) and Wilms tumor-1 protein (WT1) are key markers in renal tumor diagnostics.
Observation:
- Unexpected nuclear TTF-1 immunoreactivity was noted in a nephroblastoma metastasis.
- This contrasted with a lack of WT1 immunoreactivity in the same case.
- This prompted an investigation into TTF-1, WT1, and CD56 expression in various renal tumors.
Findings:
- TTF-1 was positive in 16.6% of nephroblastomas but negative in adult metanephric adenomas.
- WT1 was highly expressed in nephroblastomas (89.6%) and metanephric adenomas (80%).
- CD56 was positive in most nephroblastomas (95.7%) but negative in metanephric adenomas.
Implications:
- TTF-1 expression in nephroblastomas poses a potential diagnostic challenge, risking misclassification.
- The biological role of TTF-1 in nephroblastoma development is currently unknown.
- This finding may indicate an embryonal origin or interfere with transcriptional regulation in nephroblastoma development.
